Rhumbline Advisers Boston Scientific Corp Transaction History

Rhumbline Advisers

  • $105 Billion
  • Q2 2024

A detailed history of Rhumbline Advisers transactions in Boston Scientific Corp stock. As of the latest transaction made, Rhumbline Advisers holds 2,959,422 shares of BSX stock, worth $244 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,959,422
Previous 2,970,888 0.39%
Holding current value
$244 Million
Previous $203 Million 12.01%
% of portfolio
0.22%
Previous 0.2%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$67.33 - $77.71 $772,005 - $891,022
-11,466 Reduced 0.39%
2,959,422 $228 Million
Q1 2024

May 09, 2024
BUY
$57.6 - $68.62 $841,075 - $1 Million
14,602 Added 0.49%
2,970,888 $203 Million
Q4 2023

Feb 08, 2024
BUY
$48.64 - $57.81 $419,957 - $499,131
8,634 Added 0.29%
2,956,286 $171 Million
Q3 2023

Nov 09, 2023
BUY
$50.19 - $54.68 $1.21 Million - $1.32 Million
24,133 Added 0.83%
2,947,652 $156 Million
Q2 2023

Aug 08, 2023
BUY
$49.72 - $54.64 $773,543 - $850,089
15,558 Added 0.54%
2,923,519 $158 Million
Q1 2023

May 11, 2023
SELL
$45.09 - $50.03 $776,089 - $861,116
-17,212 Reduced 0.59%
2,907,961 $145 Million
Q4 2022

Feb 14, 2023
BUY
$39.56 - $47.22 $7.7 Million - $9.19 Million
194,639 Added 7.13%
2,925,173 $135 Million
Q3 2022

Nov 10, 2022
BUY
$36.71 - $109.66 $2.45 Million - $7.31 Million
66,703 Added 2.5%
2,730,534 $106 Million
Q2 2022

Aug 11, 2022
BUY
$35.24 - $47.1 $3.48 Million - $4.65 Million
98,798 Added 3.85%
2,663,831 $99.3 Million
Q1 2022

May 12, 2022
BUY
$40.9 - $45.1 $3.14 Million - $3.46 Million
76,742 Added 3.08%
2,565,033 $114 Million
Q4 2021

Feb 10, 2022
BUY
$38.07 - $44.87 $667,976 - $787,289
17,546 Added 0.71%
2,488,291 $106 Million
Q3 2021

Nov 12, 2021
SELL
$41.23 - $45.88 $3.29 Million - $3.66 Million
-79,749 Reduced 3.13%
2,470,745 $107 Million
Q2 2021

Aug 05, 2021
SELL
$38.58 - $44.24 $4.8 Million - $5.5 Million
-124,331 Reduced 4.65%
2,550,494 $109 Million
Q1 2021

May 06, 2021
SELL
$35.27 - $39.67 $6.47 Million - $7.28 Million
-183,581 Reduced 6.42%
2,674,825 $103 Million
Q4 2020

Feb 10, 2021
BUY
$33.15 - $41.97 $1.9 Million - $2.41 Million
57,397 Added 2.05%
2,858,406 $103 Million
Q3 2020

Nov 12, 2020
SELL
$34.44 - $42.23 $314,437 - $385,559
-9,130 Reduced 0.32%
2,801,009 $107 Million
Q2 2020

Aug 13, 2020
BUY
$30.19 - $39.11 $1.99 Million - $2.58 Million
65,962 Added 2.4%
2,810,139 $98.7 Million
Q1 2020

May 06, 2020
BUY
$25.83 - $45.71 $2.22 Million - $3.93 Million
85,952 Added 3.23%
2,744,177 $89.5 Million
Q4 2019

Feb 05, 2020
BUY
$37.87 - $45.37 $889,187 - $1.07 Million
23,480 Added 0.89%
2,658,225 $120 Million
Q3 2019

Oct 23, 2019
BUY
$40.31 - $43.45 $2.45 Million - $2.64 Million
60,662 Added 2.36%
2,634,745 $107 Million
Q2 2019

Aug 14, 2019
SELL
$34.91 - $42.98 $873,203 - $1.08 Million
-25,013 Reduced 0.96%
2,574,083 $111 Million
Q1 2019

May 01, 2019
BUY
$32.91 - $40.75 $3.3 Million - $4.09 Million
100,341 Added 4.02%
2,599,096 $99.8 Million
Q4 2018

Jan 31, 2019
BUY
$31.73 - $39.04 $1.55 Million - $1.91 Million
48,890 Added 2.0%
2,498,755 $88.3 Million
Q3 2018

Nov 07, 2018
SELL
$32.83 - $38.63 $1.17 Million - $1.38 Million
-35,756 Reduced 1.44%
2,449,865 $94.3 Million
Q2 2018

Aug 06, 2018
BUY
$26.84 - $34.32 $2.35 Million - $3.01 Million
87,665 Added 3.66%
2,485,621 $81.3 Million
Q1 2018

May 02, 2018
SELL
$25.2 - $28.54 $663,868 - $751,857
-26,344 Reduced 1.09%
2,397,956 $65.5 Million
Q4 2017

Feb 09, 2018
BUY
$24.79 - $29.8 $1.34 Million - $1.61 Million
54,174 Added 2.29%
2,424,300 $60.1 Million
Q3 2017

Nov 06, 2017
BUY
$26.26 - $29.17 $62.2 Million - $69.1 Million
2,370,126
2,370,126 $69.1 Million

Others Institutions Holding BSX

# of Institutions
1,448
Shares Held
1.21B
Call Options Held
8.14M
Put Options Held
8.3M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $118B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email